Search

everythinglearnresearchcommunity

for

Search:↓

A patient with untreated congenital adrenal hyperplasia had large benign tumors in her adrenal glands removed, improving her symptoms.

Polycystic ovary syndrome is found in 6.5% of unselected Caucasian women in Spain.

The NAMS 2014 recommendations guide healthcare providers on treating health issues in midlife women, emphasizing individualized care and informed decision-making.

Adding anti-Müllerian hormone to PCOS criteria lowers the number of women diagnosed.

Most women with hirsutism or androgenic alopecia had polycystic ovaries, especially if they had irregular periods.

Hormones, especially androgens, play a big role in acne, but most acne sufferers don't have a hormone disorder. Hormonal treatments, including birth control pills, can be very effective for women whose acne doesn't improve with regular treatments.

The update highlights that non-classic congenital adrenal hyperplasia is common in women with excess male hormones, requires specific hormone tests for diagnosis, and has various treatment options depending on age and symptoms.

Certain genetic variations in the AR and ERβ genes can affect androgen levels in women.

Finasteride reduces hair growth better, but spironolactone has more side effects.

The document concludes that careful evaluation is key to diagnose and treat women with hair loss, with tests for thyroid, iron, and hormones as needed.

Women with acromegaly often have irregular periods due to hormone imbalances and growth hormone effects.

Androgens play a complex role in skin conditions like acne and hair loss in women, and normal blood levels don't always show true androgen status.

Short-term testosterone therapy in women seems safe with few mild side effects, but long-term effects need more research.

Longer CAG repeat lengths in the androgen receptor gene are linked to higher testosterone levels in women with PCOS.

The conclusion is that oral contraceptives and antiandrogens can treat hirsutism and acne in women with cutaneous hyperandrogenism, but more research is needed for effective treatments, especially for hair loss.

The document explains hair biology, the causes of hair loss, and reviews various hair loss treatments.

Recent genetic insights show that low-renin hypertension includes a range from essential hypertension to secondary or familial forms, affecting diagnosis and treatment.

The document concludes that menopause should be seen as a natural part of aging and managed with personalized care and informed choices.

The conclusion is that removing both ovaries is the best treatment for excess male hormones in postmenopausal women, with medication as another option, and managing insulin resistance is important for diagnosis and treatment.

Women with mild acne are more likely to have polycystic ovary syndrome (PCOS) than those without acne.

Isotretinoin improves severe acne without changing androgen or insulin levels but may increase body weight and triglycerides.

Most treatments for hair loss in 1997 were not effective for most people, and maintaining hair growth was difficult.

Women experience various skin issues at different life stages, requiring careful treatment and awareness.

Obesity changes androgen levels in women with PCOS, leading to higher testosterone relative to androstenedione.

A low-starch/low-dairy diet may help overweight women with PCOS lose weight and improve metabolism, but more research is needed.

Overweight women with PCOS have higher levels of certain hormones that could indicate a higher risk of heart and metabolic problems.

Excessive hair growth in women can be harmless or signal serious health issues, and treatment often includes medication and hair removal, with noticeable results after 3-6 months.

The conclusion is that young women with excessive hair growth should be quickly tested for hormonal issues and treated to improve their social well-being.

Women with PCOS have similar bone density to healthy women, but those who are obese have higher bone density at some body sites.

Sex steroids, especially progesterone, can slow down the growth of mouse melanoma cells.